4

OWNERSHIP DOCUMENT

Company: Aclaris Therapeutics, Inc.
Filed: October 30, 2015
Period of Report: October 28, 2015
Accession Number: 0001144204-15-061891

View Document ↗ View on SEC.gov ↗